X0306
4
2015-06-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001215126
MCGLYNN MARGARET G
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-06-01
4
M
0
5000
57.27
A
6088
D
Common Stock
2015-06-01
4
M
0
7500
53.85
A
13588
D
Common Stock
2015-06-01
4
S
0
3480
126.78
D
10108
D
Common Stock
2015-06-01
4
S
0
9020
127.53
D
1088
D
Stock Option
127.54
2015-06-01
4
A
0
20000
0.00
A
2015-06-01
2025-05-31
Common Stock
20000
20000
D
Stock Option (right to buy)
57.27
2015-06-01
4
M
0
5000
0.00
A
2021-05-11
Common Stock
5000
25000
D
Stock Option (right to buy)
53.85
2015-06-01
4
M
0
7500
0.00
A
2021-05-31
Common Stock
7500
0
D
Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $126.78 (range $126.11 to $127.07).
Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $127.53 (range $127.11 to $128.05).
Fully vested.
Omar White, Attorney-In-Fact
2015-06-03